DVOSKIN v. BIO-REFERENCE LABORATORIES, INC.

CourtDistrict Court, D. New Jersey
DecidedMay 26, 2021
Docket2:18-cv-10667
StatusUnknown

This text of DVOSKIN v. BIO-REFERENCE LABORATORIES, INC. (DVOSKIN v. BIO-REFERENCE LABORATORIES, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DVOSKIN v. BIO-REFERENCE LABORATORIES, INC., (D.N.J. 2021).

Opinion

NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

MITCHELL DVOSKIN,

Plaintiff, Civil Action No. 18-10667 v. OPINION BIO-REFERENCE LABORATORIES, INC., et al.,

Defendants.

ARLEO, UNITED STATES DISTRICT JUDGE THIS MATTER comes before the Court on Defendants Bio-Reference Laboratories, Inc.’s (“BRLI”) and OPKO Health, Inc.’s (“OPKO” and together with BRLI, “Defendants”) Motion for Summary Judgment pursuant to Federal Rule of Civil Procedure 56. ECF No. 38. Plaintiff Mitchell Dvoskin (“Plaintiff”) opposes the Motion. ECF No. 39. For the reasons explained below, the Motion is GRANTED IN PART and DENIED IN PART. I. FACTUAL BACKGROUND1 This matter arises from Defendants’ termination of Plaintiff, a software developer. See generally Compl., ECF No. 1. Plaintiff alleges age discrimination, disability discrimination, and retaliation under New Jersey and federal law.

1 These facts are drawn from Defendants’ Statement of Undisputed Material Facts (“DSUF”), ECF No. 38.4, Plaintiff’s Statement of Additional Facts (“PSAF”), ECF No. 39.3, and the relevant record. Disputes of fact are noted. Plaintiff was born on July 22, 1954 and was 63 years of age at the time of his termination. PSAF ¶ 1. He has a history of coronary issues, including corroded arteries, a 2012 stent procedure, and a 2017 triple bypass surgery. Id. ¶¶ 8, 33. BRLI hired Plaintiff on June 14, 2010 to work in its IT department and perform tasks

related to a proprietary billing software called “Vertex.” DSUF ¶ 1. Plaintiff primarily reported to Wolfgang Pillon (“Pillon”), a third-party contractor of Plaintiff who owned the Vertex software. Pl. Dep Tr. 20:12-14, 51:2-12, Pl. Ex. T, ECF No. 39.7. According to Plaintiff, he was hired after BRLI became concerned that if Pillon were to retire or die, there would be no one able to keep the Vertex software operational. Id. at 51:14-53:2. Plaintiff further testified that he was hired specifically to work on Vertex and that Vertex accounted for 90 to 95% of his work during his employment, although he occasionally worked on other assignments. DSUF ¶ 3; Pl. Dep. Tr. 27:6- 28:25. Beginning in 2010 or 2011, BRLI began discussions to phase out Vertex in favor of a new automated billing system called “XIFIN.” PSAF ¶ 13.2 By as early as 2015, BRLI developed a two-pronged phase out of Vertex, which Defendants3 ultimately implemented. In accordance with

the planned phase out, XIFIN would first launch on October 1, 2016, and thereafter no new billing information would be processed through Vertex. DSUF ¶ 4; PSAF ¶13. Second, Vertex would shut down on October 1, 2017, except for certain maintenance and archival-related tasks. DSUF ¶ 4; PSAF ¶13. BRLI Vice President of Finance Kevin Feeley (“Feeley”) testified that “as early

2 Plaintiff was told at the time of his hire that Vertex would eventually be phased out. DSUF ¶ 3; Pl. Dep Tr. 50:4-9, 52:3-6. 3 OPKO acquired BRLI in or about June 2015. DSUF ¶ 15. Pursuant to the merger agreement, OPKO assumed control of all BRLI operations as of December 31, 2016. PSAF ¶ 6. as February 2017,” he issued a “directive that any and all individuals associated with [Vertex] . . . would have their positions at the company eliminated.”4 DSUF ¶ 11. On March 7 or 8, 2017, Plaintiff informed Pillon that he would be absent on March 9 and March 10 to undergo a coronary procedure.5 Following the procedure, Plaintiff learned that he

would require triple bypass surgery. PSAF ¶ 31. On March 10, 2017, Plaintiff informed Pillon and Chief Information Officer John Mooney (“Mooney”) of his need for surgery and medical leave. Id. ¶ 32. Plaintiff thereafter initiated a leave of absence pursuant to the Family Medical Leave Act, 29 U.S.C. §§ 2601, et seq. (“FMLA”) from March 17 to May 1, 2017. Id. ¶¶ 33, 37; DSUF ¶ 28. Upon Plaintiff’s return to work, Mooney informed Plaintiff that he would be transferred out of the IT department into the billing department, that he would now report to Steve Washburn (“Washburn”), and that Plaintiff did not have the option to remain within IT. PSAF ¶¶ 37-38.6 Plaintiff testified that before his leave, he performed custom software development, always had at least forty hours of work each week, and had the title of “Systems Developer.” Id. ¶ 39. After his

transfer to the billing department, Plaintiff was reclassified as a “Data Analyst.” Id. In his new role, Plaintiff had a reduced workload and performed “less-complex, lower-level work, including substantial amounts of clerical work, which he’d not been performing previously.” Id. However, Plaintiff testified that despite the change in departments, he continued to work primarily on the Vertex system. Pl. Dep. Tr. 103:1-7.7

4 No evidence suggests that Plaintiff knew of Feeley’s directive. 5 Plaintiff testified that this conversation took place “a day or two” before his procedure. Pl. Dep. Tr. 204:17-25. 6 Feeley, Mooney, and Washburn were each involved in the decision to transfer Plaintiff. See Feeley Dep. Tr. 88:5-23, 113:4-16, Pl. Ex. U, ECF No. 39.8. 7 Defendants maintain that Plaintiff performed the same job before and after his medical leave, though they concede that Plaintiff served a different function following the transfer. See DSUF ¶ 32. According to Defendants, any change or reduction in Plaintiff’s duties was the natural result of the Vertex phase out. In June and July 2017, Plaintiff made several formal and informal complaints to Defendants regarding his transfer. On June 27, Plaintiff called a Human Resources (“HR”) representative and expressed his view that the transfer was a violation of the FMLA and a precursor to a termination based on his disability. PSAF ¶ 53. Plaintiff submitted a written complaint

reiterating his concerns on June 29. Id. ¶ 54. On July 5, he met with Monika Lee (“Lee”), an HR representative, to discuss his complaints of age, disability, and FMLA discrimination. Id. ¶ 57. Plaintiff also complained to Washburn and Pillon about his perceived discrimination. Id. ¶ 60. On July 31, 2017, Plaintiff submitted a second written complaint to Lee, repeating his complaints of age, disability, and FMLA discrimination. Id. ¶ 70. Lee circulated this complaint to Washburn, who forwarded it to Feeley and Mooney. PSAF ¶ 77; Pl. Ex. D, ECF No. 39.4. On August 2, Feeley responded directly to Lee, asking for a meeting so they could “map out the path forward to termination together.” PSAF ¶ 84; Pl. Ex. D. The same day, Lee responded to Plaintiff informing him that Defendants disagreed with his FMLA and discrimination claims. PSAF ¶ 103; Pl. Ex. Q, ECF No. 39.6.

During this same period, in or around July 2017, Plaintiff formally applied for four open billing and IT positions with BRLI: “Business Analyst,” “QA Analyst,” “Data Analyst,” and “HL 7 Integration Developer.” Compl. ¶ 58; Pl. Dep Tr. 145:2-17, 150:9-151:2.8 Defendants required current employees seeking a new position to apply through its Talent Acquisition department (“TA”). Pl. Dep Tr. 22:20-24:2; see also Declaration of Jeanne Calton (“Calton Decl.”) ¶ 2, ECF No. 38.2.9 TA operates separately from the HR department and performs an “independent inquiry”

8 In opposition to Defendants’ Motion, Plaintiff contends that he applied for nine open positions. PSAF ¶ 62. As the allegations of five additional positions were not pled in the Complaint, the Court considers only the four positions noted above in assessing Plaintiff’s failure to hire claims. 9 Plaintiff argues that the Court should exclude the Calton Declaration from consideration because it was not disclosed until after the close of discovery.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sulima v. Tobyhanna Army Depot
602 F.3d 177 (Third Circuit, 2010)
First Nat. Bank of Ariz. v. Cities Service Co.
391 U.S. 253 (Supreme Court, 1968)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Marra v. Philadelphia Housing Authority
497 F.3d 286 (Third Circuit, 2007)
Erdman v. Nationwide Insurance
582 F.3d 500 (Third Circuit, 2009)
Hohider v. United Parcel Service, Inc.
574 F.3d 169 (Third Circuit, 2009)
Craig v. Suburban Cablevision, Inc.
660 A.2d 505 (Supreme Court of New Jersey, 1995)
Dungee v. Northeast Foods, Inc.
940 F. Supp. 682 (D. New Jersey, 1996)
Patricia Karaffa v. Township of Montgomery
560 F. App'x 133 (Third Circuit, 2014)
Budhun v. Reading Hospital & Medical Center
765 F.3d 245 (Third Circuit, 2014)
Dorothy Daniels v. Philadelphia School District
776 F.3d 181 (Third Circuit, 2015)
Richard Beese v. Meridian Health Systems Inc
629 F. App'x 218 (Third Circuit, 2015)
Donielle Hoist v. State of New Jersey
642 F. App'x 169 (Third Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
DVOSKIN v. BIO-REFERENCE LABORATORIES, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/dvoskin-v-bio-reference-laboratories-inc-njd-2021.